FLGT logo

Fulgent Genetics, Inc. Common Stock


FLGT: Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.


Show FLGT Financials

Consumer Interest
SEC Filings

Recent trades of FLGT by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by FLGT's directors and management

Government lobbying spending instances

  • $50,000 Jan 20, 2023 Issue: Health Issues
  • $100,000 Oct 20, 2022 Issue: Health Issues
  • $20,000 Oct 19, 2022 Issue: Health Issues
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases


Number of mentions of FLGT in WallStreetBets Daily Discussion


Recent insights relating to FLGT

CNBC Recommendations

Recent picks made for FLGT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in FLGT

Corporate Flights

Flights by private jets registered to FLGT